Covid-19 roundup: As AstraZeneca deals with vaccine woes, US turns attention to its antibody treatment; Moderna doses first kids in pediatric vaccine study

As countries around the world halt the distribution of AstraZeneca’s Covid-19 vaccine due to reports of blood clots, the US is more focused on …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: As As­traZeneca deals with vac­cine woes, US turns at­ten­tion to its an­ti­body treat­ment; Mod­er­na dos­es first kids in pe­di­atric vac­cine study